| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |